Completely relieved for up to 8 years! China’s innovative CAR-T therapy brings the dawn of “cure” for advanced cancer

Two long-term disease-free survival cases of advanced liver cancer treated with CAR-GPC3 T cell therapy developed by Chinese scientists were published in the internationally renowned immunology journal Cancer Communications. One of the patients has achieved complete remission of the tumor for 8 years, which is a major breakthrough in China’s anti-cancer research. This therapy is expected to cure solid tumors through innovative treatment strategies, bringing new hope to patients with advanced liver cancer.